MedTrace Logo

Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction

NCT07250152 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1544

Last updated 2025-11-26

No results posted yet for this study

Summary

Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.

Conditions

  • Myocardial Infarction (MI)

Interventions

PROCEDURE

Percutaneous coronary intervention

Percutaneous coronary intervention

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2027-09-30
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07250152 on ClinicalTrials.gov